ASP Isotopes Inc. 8K

ASP Isotopes’ subsidiary Noble Africa agreed to merge with a subsidiary of ENDRA Life Sciences and raise about $50 million in a concurrent private placement to form a new Nasdaq‑listed helium development platform, Noble Africa Inc., majority‑owned by ASP Isotopes.

ASP Isotopes Inc. announced that its wholly owned subsidiary Noble Africa LLC, the intermediate holding company for Renergen Limited, has entered into a merger agreement with a subsidiary of ENDRA Life Sciences Inc., pursuant to which Noble Africa will be the surviving entity and, together with related transactions, will form a new Nasdaq-listed company to be named Noble Africa Inc. under the ticker “NOBA,” alongside a concurrent private placement expected to raise approximately $50 million in gross proceeds (including about $20 million from ASP Isotopes and $30 million from other investors, such as ASP directors and management), to support the Virginia Gas Project’s Phase 1 and Phase 2 development. Upon closing, anticipated in the third or fourth quarter of 2026 subject to SEC registration effectiveness, ENDRA stockholder approval and customary conditions, ASP Isotopes is expected to own roughly 89% of the combined company, pre-closing ENDRA stockholders about 3%, and other private placement investors about 7%, with the combined company initially led by Paul E. Mann and Nick Mitchell and governed by a six‑member board predominantly designated by ASP Isotopes.

Filing Facts

CIK

1921865

Ticker

-

Form

8K

Source Type

sec

Accession

0001193125-26-282048

Alert Tier

8